Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 47 - Sayı: 1

Androgenetic Alopecia

Androgenetik Alopesi

Pages
141–149
Publication Date
2021-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it is aimed to provide information about current treatment methods in the management of androgenetic alopecia in men and women.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Androgenetic alopecia is a form of hair loss that can occur with different pathological mechanisms in people with genetic predisposition, and the clinic may vary in men and women.
📊
Key Findings & Data:The purpose of the management of androgenetic alopecia is to stop follicular miniaturization and to increase hair density.
💡
Conclusion & Impact:In this review, it is aimed to provide information about current treatment methods in the management of androgenetic alopecia in men and women.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Androgenetik alopesi · patogenez · hasta yönetimi

Abstract

Androgenetic alopecia is a form of hair loss that can occur with different pathological mechanisms in people with genetic predisposition, and the clinic may vary in men and women. Although androgenetic alopecia is common and its diagnosis is usually easy, there is no standard treatment guideline for patient management. The purpose of the management of androgenetic alopecia is to stop follicular miniaturization and to increase hair density. Therapies used in the management of androgenetic alopecia are potassium ion channel modifiers (topical minoxidil and oral minoxidil), 5α reductase inhibitors (oral finasteride, topical finasteride and oral dutasteride), androgen receptor antagonists (spironolactone, cyproterone acetate, flutamide, cortexolone 17 alpha propionate solution and topical minoxidil) , other medical treatments (topical prostaglandin analogues, topical ketoconazole, topical melatonin, Wnt / β catenin signaling pathway activators and JAK-STAT pathway inhibitors), physical treatments (low-grade laser light therapy, laser treatments, microneedling, mesotherapy, PRP and stem cell treatments), complementary therapies (hair transplantation, nutritional supplements and camouflage methods) and combination therapies. In this review, it is aimed to provide information about current treatment methods in the management of androgenetic alopecia in men and women.

Özet

Androgenetik alopesi genetik yatkınlığı olan kişilerde farklı patolojik mekanizmalarla ortaya çıkabilen, erkek ve kadınlarda kliniği değişiklik gösterebilen bir saç dökülme şeklidir. Androgenetik alopesi her ne kadar sık görülüyor ve tanısı genellikle kolay koyuluyor olsa da hasta yönetimi için standart bir tedavi rehberi yoktur. Androgenetik alopesi yönetiminde amaç foliküler minyatürizasyonu durdurmak ve saç dansitesini arttırmaktır. Androgenetik alopesi yönetiminde kullanılan tedaviler potasyum iyon kanalı düzenleyicileri (topikal minoksidil ve oral minoksidil), 5α redüktaz inhibitörleri (oral finasterid, topikal finasterid ve oral dutasterid), androjen reseptör antagonistleri (spironolak-ton, siproteron asetat, flutamid, korteksolon 17 alfa propionat ve topikal fluridil), diğer medikal tedaviler (topikal prostoglandin analogları, topikal ketokonazol, topikal melatonin, Wnt/β katenin sinyal yolağı aktivatörleri ve JAK-STAT yolağı inhibitörleri), fiziksel tedaviler (düşük dereceli lazer ışık tedavisi, lazer tedavileri, mikroiğneleme, mezoterapi, PRP ve kök hücre tedavileri), tamamlayıcı tedaviler (saç transplantasyonu, besin takviyeleri ve kamuflaj yöntemleri) ve kombinasyon tedavileridir. Bu derlemede erkek ve kadında androgenetik alopesi yönetiminde güncel tedavi yöntemleri hakkında bilgi verilmesi amaçlanmıştır.

🔖

Cite This Article

ŞAHİN, G., ÖZDEMİR, H., AYDIN, F. (2021). Androgenetic Alopecia. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 47 - Sayı: 1, 141–149. https://ajindex.com/articles/134685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Referans1 Rhodes T, Girman CJ, Savin RC, et al. Prevalence of male pattern hair loss in 18-49 year old men. Dermatol Surg 1998
  2. 24(12):1330-2. Referans2 Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001
  3. 27(1):53-4. Referans3 Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 2001
  4. 145(1):95-9. Referans4 Heilmann-Heimbach S, Hochfeld LM, Paus R, Nöthen MM. Hunting the genes in male-pattern alopecia: how important are they, how close are we and what will they tell us? Exp Dermatol 2016
  5. 25(4):251-7. Referans5 Tosti A, Iorizzo M, Piraccini BM. Androgenetic alopecia in children: report of 20 cases. Br J Dermatol 2005
  6. 152(3):556-9. Referans6 Sperling LC, Sinclair RD, Shabrawi-Caelen LE: Alopecias. In Bolognia JL, Schaffer JV, Cerroni L (eds): Dermatology. Forth Edition. Elsevier, 2018. pp. 1162-87. Referans7 Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 2002
  7. 198(1-2):51-9. Referans8 Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997
  8. 109(3):296-300. Referans9 Sawaya ME. Purification of androgen receptors in human sebocytes and hair. J Invest Dermatol 1992
  9. 98(6 Suppl):92S-96S. Referans10 Garza LA, Liu Y, Yang Z, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald skalpof men with androgenetic alopecia. Sci Transl Med 2012
  10. 126ra34 Referans11 Schmidt JB, Lindmaier A, Trenz A, Schurz B, Spona J. Hormone studies in females with androgenic hairloss. Gynecol Obstet Invest 1991
  11. 31(4):235-9. Referans12 Yip L, Rufaut N, Sinclair R. Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. Australas J Dermatol. 2011
  12. 52(2):81-8. Referans13 Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975
  13. 68(11):1359-65. Referans14 Olsen EA. Female pattern hair loss. J Am Acad Dermatol 2001
  14. 45(3 Suppl):S70-80. Referans15 Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977
  15. 97(3):247-54. Referans16 Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 1999
  16. 141(3):398-405. Referans17 Arias-S